Credit Suisse’s PepGen PEPG Stock Holding History

Credit Suisse’s Portfolio PEPG Stock Details PEPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	-$13	–	3599
2022 Q4	$13	Sell	1 -52	-98%	-$671	﹤0.01%	3704
2022 Q3	$0	Buy	53 +49	+1,225%	+$482	﹤0.01%	4216
2022 Q2	$0	Buy	+4	New	+$45	﹤0.01%	4209

Other funds holding PEPG

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's PEPG Position: Q1 2023 in Review

Credit Suisse sold out of PepGen (PEPG) in Q1 2023, closing a stake of 1 share — an estimated $13 sold.

Credit Suisse first reported a position in PEPG in Q2 2022 and held it in 3 quarters. The position peaked at $13 in Q4 2022. 45 funds tracked by Wall St. Rank hold PEPG as of Q1 2023.

Credit Suisse reported no remaining PepGen position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 1 PepGen share in Q1 2023, an estimated $13.
Credit Suisse first reported a position in PepGen in Q2 2022 and held it in 3 quarters.
Credit Suisse's PepGen position peaked at $13 in Q4 2022.
45 funds tracked by Wall St. Rank held PepGen as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.